EV/EBITDA:
228.60+2.19(+0.97%)Summary
- As of today, XERS EV/EBITDA is 228.60, with a rise of +2.19 (+0.97%) during the most recent trading session on October 17, 2025.
- Over the past year, XERS EV/EBITDA has increased by +256.98 (+905.50%).
- XERS EV/EBITDA is now -0.28% below its all-time high of 229.25.
Performance
XERS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
XERS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +1.0% | +1.0% | +1.1% |
| 1M1 Month | +17.6% | +17.6% | +20.5% |
| 3M3 Months | +62.3% | +62.3% | +76.7% |
| 6M6 Months | +216.3% | +98.1% | +124.8% |
| YTDYTD | +552.9% | +139.3% | +172.6% |
| 1Y1 Year | +905.5% | +158.2% | +203.9% |
| 5Y5 Years | +10000.0% | +687.1% | +81.9% |
XERS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 229.25 | -0.3% | 194.30 | +17.6% |
| 3M | 3-Month | 229.25 | -0.3% | 135.81 | +68.3% |
| 6M | 6-Month | 229.25 | -0.3% | -238.93 | +195.7% |
| 1Y | 1-Year | 229.25 | -0.3% | -245.87 | +193.0% |
| 3Y | 3-Year | 229.25 | -0.3% | -245.87 | +193.0% |
| 5Y | 5-Year | 229.25 | -0.3% | -245.87 | +193.0% |
| All-Time | All-Time | 229.25 | -0.3% | -245.87 | +193.0% |
XERS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 228.60(+552.9%) |
| 2024 | -50.48(-148.9%) |
| 2023 | -20.28(-436.5%) |
| 2022 | -3.78(-22.3%) |
| Date | Value |
|---|---|
| 2021 | -3.09(+1.0%) |
| 2020 | -3.12(-110.8%) |
| 2019 | -1.48(+75.1%) |
| 2018 | -5.94 |
FAQ
- What is Xeris Biopharma Holdings, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Xeris Biopharma Holdings, Inc.?
- What is XERS EV/EBITDA year-to-date change?
- What is Xeris Biopharma Holdings, Inc. EV/EBITDA year-on-year change?
What is Xeris Biopharma Holdings, Inc. EV/EBITDA?
The current EV/EBITDA of XERS is 228.60
What is the all-time high EV/EBITDA for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high EV/EBITDA is 229.25
What is XERS EV/EBITDA year-to-date change?
Xeris Biopharma Holdings, Inc. EV/EBITDA has changed by +279.08 (+552.85%) since the beginning of the year
What is Xeris Biopharma Holdings, Inc. EV/EBITDA year-on-year change?
Over the past year, XERS EV/EBITDA has changed by +256.98 (+905.50%)